Method for synthesizing SAPO-41 (Phosphoric Acid Silicon-Aluminum-41) molecular sieve by adopting novel template agent
A SAPO-41, a new template technology, applied in molecular sieve and alkali-exchanged phosphate, molecular sieve-specific silicoaluminophosphate, etc., can solve the problems of mixed crystals, unfavorable large-scale industrial production, and high preparation cost, and reduce synthesis costs. , to achieve the effect of large-scale industrial production and low price
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0009] Specific embodiment one: this embodiment is a kind of method that adopts novel templating agent to synthesize SAPO-41 molecular sieve, specifically is to carry out according to the following steps:
[0010] 1. Add phosphoric acid, pseudoboehmite, di-n-butylamine and silica sol with a mass fraction of 85% into deionized water in sequence, and stir at a speed of 500r / min~2000r / min for 1h~8h to obtain the initial Gel; 2. Place the initial gel obtained in step 1 in a polytetrafluoroethylene-lined stainless steel crystallization kettle, crystallize at 160°C~200°C for 2h~72h, then cool to room temperature, and cool to room temperature to produce The crystallized product was centrifuged, washed and dried at 100°C~200°C for 10h~24h in sequence, and finally calcined at 500°C~700°C for 4h~30h, and naturally cooled to room temperature to obtain SAPO-41 molecular sieve.
[0011] The mass fraction described in step one of the present embodiment is that the mass ratio of phosphoric a...
specific Embodiment approach 2
[0016] Specific embodiment two: the difference between this embodiment and specific embodiment one is: the mass ratio of phosphoric acid with a mass fraction of 85% and pseudo-boehmite described in step one is 1:(0.5~1.9). Others are the same as the first embodiment.
specific Embodiment approach 3
[0017] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is that the mass fraction of phosphoric acid and di-n-butylamine described in step one is 1:(12~2.1) . Others are the same as the second or third specific embodiment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com